The International Trachoma Initiative (ITI) was founded in 1998 in response to the World Health Organization’s call to eliminate blinding trachoma by the year 2020 (GET2020). ITI’s founding partners, Pfizer and the Edna McConnell Clark Foundation saw the need for an international nongovernmental organization dedicated solely to preventing blinding trachoma.
This manual has been written for use by trachoma program managers and other partners to support and guide the planning, implementation, and evaluation of the antibiotic component of the SAFE strategy.
While antibiotics alone will not eliminate blinding trachoma and sustain its elimination, the generous donation of Zithromax® by Pfizer Inc. is enabling countries to move forward more quickly towards their elimination goals.
Alternative antibiotic therapies are available for endemic countries that are not included in the ITI program. This guide, however, was written especially for Pfizer Inc.’s donation of Zithromax®. The drug donation also allows the global trachoma community to mobilize the additional resources and support necessary for the goal of GET2020 to become a reality.
The International Trachoma Initiative, 2010
Access the full guide at http://trachoma.org/sites/default/files/guidesandmanuals/Zithromax%20manager’s%20guide.pdf
Original Source: iapb.org